早期年轻子宫内膜癌患者孕激素治疗的疗效及安全性分析

邢洁; 谢幸

doi:10.3969/j.issn.1007-3969.2014.12.009

您当前的位置：

首页 >

文章列表页 >

早期年轻子宫内膜癌患者孕激素治疗的疗效及安全性分析

更新时间：2025-12-31

- 早期年轻子宫内膜癌患者孕激素治疗的疗效及安全性分析
- Efficacy and safety of fertility-sparing treatment with progesterone in young patients with early endometrial carcinoma
- 中国癌症杂志 2014年24卷第12期页码：931-935
- 作者机构：
  
  浙江省肿瘤医院肿瘤妇科,浙江,杭州,310022
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2014.12.009
  中图分类号：
- 网络出版：2015-05-07，
  
  纸质出版：2014-05-07
- 稿件说明：
移动端阅览
邢洁,谢幸,于爱军等. 早期年轻子宫内膜癌患者孕激素治疗的疗效及安全性分析[J]. 中国癌症杂志, 2014, 24(12): 931-935.

邢洁, 谢幸. Efficacy and safety of fertility-sparing treatment with progesterone in young patients with early endometrial carcinoma[J]. China Oncology, 2014, 24(12): 931-935.
邢洁,谢幸,于爱军等. 早期年轻子宫内膜癌患者孕激素治疗的疗效及安全性分析[J]. 中国癌症杂志, 2014, 24(12): 931-935. DOI： 10.3969/j.issn.1007-3969.2014.12.009.

邢洁, 谢幸. Efficacy and safety of fertility-sparing treatment with progesterone in young patients with early endometrial carcinoma[J]. China Oncology, 2014, 24(12): 931-935. DOI： 10.3969/j.issn.1007-3969.2014.12.009.

摘要

背景与目的：随着近年来子宫内膜癌在年轻人中发病率的上升，孕激素保守治疗受到关注。本研究探讨孕激素保守治疗年轻早期子宫内膜癌患者的效果及对预后的影响。方法：回顾性分析2002—2014年浙江省肿瘤医院及浙江大学附属妇产科医院共19例早期年轻子宫内膜癌患者激素治疗的相关资料。结果：19例患者中首次治疗完全缓解率为68.4%，复发率为15.4%，妊娠生育率为46.2%，平均随访时间为87.9个月。结论：激素治疗是有生育要求的早期子宫内膜癌患者实现妊娠的有效方案，但相比传统治疗方案存在一定的复发风险。

Abstract

Background and purpose: The morbidity rate of endometrial cancer is increasing in young patients these years. Fertility-sparing treatment with progesterone was concerned. The objective of this study was to evaluate the efficacy and safety of fertility-sparing treatment with progesterone in young patients with early endometrial carcinoma. Methods: The data of 19 early endometrial cancer patients fertility-sparing treatment with progestin was reviewed. These patients were treated and followed up at Zhejiang Cancer Hospital and Zhejiang Women’s Hospital from 2002 to 2014. Results: After primary treatment

68.4% of patients achieved complete response. The recurrence rate was approximately 15.4% in a median follow-up period of 87.9 months

46.2% of the patients succeed in giving birth. Conclusion: Fertility-sparing treatment with progesterone is an effective method to preserve fertility for early endometrial cancer patients. But it has inherent risks

comparing with the traditional treatment.

关键词

Keywords

references

浏览量

2839

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

原发性输卵管癌合并子宫内膜癌3例临床分析并文献回顾

小干扰RNA阻断周期蛋白依赖激酶4对子宫内膜癌细胞生物学行为的影响

PTEN对子宫内膜癌细胞株迁移和侵袭能力的影响